BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  GSK, Ionis Present “Potentially Transformative” Data from Hepatitis B Hopeful

  GSK and Ionis released promising trial data showing their investigational antisense oligonucleotide, bepirovirsen, could significantly reduce HBsAg and viral DNA levels in patients with CHB.

  June 27, 2022

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  COVID-19 Vaccine Leaders Make Progress on Omicron-Specific Boosters

  The current vaccinations still offer significant protection against severe diseases. Meanwhile, vaccine companies are progressing in designing and testing Omicron-specific booster shots.

  June 27, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Ipsen Snags Epizyme and Cancer Portfolio for a Cool $247M

  Ipsen announced it is acquiring the company and its cancer drugs, including Tazverik, which were approved for two different indications by the FDA in 2020.

  June 27, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Graphene “Tattoos” May Be the Future of Blood Pressure Monitoring

  Researchers have developed a graphene-based e-tattoo that measures blood pressure continuously and has several advantages over the traditional blood pressure cuff.

  June 27, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  More Gene Therapy Trouble for Astellas as FDA Pauses Pompe Trial

  The FDA has placed Astellas Pharma’s Phase I/II FORTIS trial on clinical hold after one of its study participants experienced a serious adverse event.

  June 27, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver Conference

  For the first time in two years, the European Association for the Study of the Liver’s International Liver Congress was back on-site with cutting-edge research in hepatology and other sectors.

  June 27, 2022

   · 

  5 min read

   · 

  Tristan Manalac
• 

  Employer Resources

  Hiring in Life Sciences is Becoming More Difficult, Study Shows

  A report by CBRE shows that finding life sciences research talent may prove extremely difficult for employers. However, there are steps you can take to find top talent for these roles.

  June 27, 2022

   · 

  3 min read

   · 

  Rosemary Scott
• 

  Drug Development

  Second UTHealth Study Suggests Flu Vaccine Offers Protection Against Alzheimer’s

  Collectively, the data set found that 5.1% of vaccinated patients went on to develop AD, while 8.5% of unvaccinated patients developed the disease.

  June 27, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Business

  Embarking on New Chapter, Zymeworks Taps Paul Moore as CSO

  Another C-suite change at Zymeworks was announced Monday, with the appointment of Paul Moore, Ph.D. as chief scientific officer.

  June 27, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Innovative Treatments on the Horizon for Anxiety Disorder

  MindMed, Scripps Research, Cingulate Therapeutics and the University of Pennsylvania discuss innovative treatments on the horizon for the treatment of anxiety disorder.

  June 27, 2022

   · 

  8 min read

   · 

  Hayley Shasteen